We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+7.66%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$455B
AUM Growth
+$26.6B
Cap. Flow
-$26.7B
Cap. Flow %
-5.87%
Top 10 Hldgs %
33.25%
Holding
16,292
New
1,466
Increased
6,223
Reduced
6,687
Closed
1,652

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$645M
2
TMUS icon
T-Mobile US
TMUS
+$640M
3
T icon
AT&T
T
+$517M
4
HUM icon
Humana
HUM
+$481M
5
BSX icon
Boston Scientific
BSX
+$400M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.24B
2
AAPL icon
Apple
AAPL
+$755M
3
META icon
Meta Platforms (Facebook)
META
+$707M
4
CAT icon
Caterpillar
CAT
+$472M
5
AMD icon
Advanced Micro Devices
AMD
+$449M

Sector Composition

Rank Sector Weight
1 Healthcare 3.33%
2 Technology 3.2%
3 Financials 2.22%
4 Industrials 2.17%
5 Consumer Discretionary 2.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IRAAW
13201
DELISTED
Iris Acquisition Corp Warrant
IRAAW
$14.7K ﹤0.01%
170,988
-510,952
-75% -$48.6K
LCI
13202
CALL
DELISTED
Lannett Company, Inc.
LCI
$14.7K ﹤0.01%
8,425
+1,075
+15% +$2.37K
HONE
13203
PUT
DELISTED
HarborOne Bancorp
HONE
$14.6K ﹤0.01%
1,200
-1,800
-60% -$24.1K
VSTM icon
13204
Verastem
VSTM
$596M
$14.6K ﹤0.01%
2,935
-15,841
-84% -$100K
ANIP icon
13205
ANI Pharmaceuticals
ANIP
$1.76B
$14.6K ﹤0.01%
368
+45
+14% +$1.9K
NTCO
13206
PUT
DELISTED
Natura &Co Holding S.A. American Depositary Shares (each representing two Common Shares)
NTCO
$14.6K ﹤0.01%
2,800
-4,400
-61% -$23.3K
ENIC icon
13207
PUT
Enel Chile
ENIC
$6.27B
$14.6K ﹤0.01%
5,400
+1,200
+29% +$2.71K
MFIN icon
13208
PUT
Medallion Financial
MFIN
$264M
$14.6K ﹤0.01%
1,900
+500
+36% +$4.02K
KULR icon
13209
CALL
KULR Technology Group
KULR
$122M
$14.6K ﹤0.01%
2,075
-7,225
-78% -$67.2K
SPIR icon
13210
CALL
Spire Global
SPIR
$567M
$14.6K ﹤0.01%
2,725
-24,438
-90% -$195K
BDTX icon
13211
CALL
Black Diamond Therapeutics
BDTX
$116M
$14.6K ﹤0.01%
7,700
-7,300
-49% -$16.8K
TRHC
13212
PUT
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$14.5K ﹤0.01%
+2,600
New +$14.9K
ORKA
13213
PUT
Oruka Therapeutics
ORKA
$7.35B
$14.5K ﹤0.01%
608
+325
+115% +$8.56K
IRS
13214
PUT
IRSA Inversiones y Representaciones
IRS
$1.24B
$14.5K ﹤0.01%
+2,392
New +$15.1K
CIO
13215
PUT
DELISTED
City Office REIT
CIO
$14.5K ﹤0.01%
2,100
-2,600
-55% -$22K
SIEN
13216
CALL
DELISTED
Sientra, Inc.
SIEN
$14.5K ﹤0.01%
9,400
+8,960
+2,036% +$15.9K
ACOR
13217
CALL
DELISTED
Acorda Therapeutics
ACOR
$14.5K ﹤0.01%
1,235
+30
+2% +$499
NMIH icon
13218
NMI Holdings
NMIH
$3.44B
$14.5K ﹤0.01%
648
-16,897
-96% -$379K
KBNT
13219
DELISTED
Kubient, Inc. Common Stock
KBNT
$14.5K ﹤0.01%
+20,952
New +$16.9K
CLSD
13220
PUT
DELISTED
Clearside Biomedical
CLSD
$14.5K ﹤0.01%
927
-246
-21% -$4.78K
JRVR icon
13221
CALL
James River Group Holdings
JRVR
$193M
$14.5K ﹤0.01%
+700
New +$15.4K
AVO icon
13222
PUT
Mission Produce
AVO
$1.15B
$14.4K ﹤0.01%
1,300
-1,500
-54% -$17.5K
EGAN icon
13223
CALL
eGain
EGAN
$206M
$14.4K ﹤0.01%
+1,900
New +$16.3K
GTIM icon
13224
CALL
Good Times Restaurants
GTIM
$16.4M
$14.4K ﹤0.01%
5,400
-14,300
-73% -$39.1K
TOVX icon
13225
Theriva Biologics
TOVX
$10.5M
$14.4K ﹤0.01%
+824
New +$17.1K

Similar funds

Ken Griffin's Q1 2023 Portfolio in Review

As of Q1 2023, Ken Griffin held 16,292 positions worth $455B, up 6.2% from $428B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Ken Griffin withdrew a net $26.7B in Q1 2023, closing 1,652 positions and reducing 6,687 holdings. Its most notable exit was Restaurant Brands International, an estimated $93.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.

Against the trend, Ken Griffin opened a new position in Keurig Dr Pepper worth $238M.

  • Ken Griffin's largest Q1 2023 buy was Keurig Dr Pepper: 6,751,572 shares worth $238M.
  • Ken Griffin added most to Invesco QQQ Trust in Q1 2023, an estimated $645M increase.
  • Ken Griffin's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.24B.
  • Ken Griffin fully exited Restaurant Brands International in Q1 2023, selling an estimated $93.3M.
  • Ken Griffin's ten largest holdings make up 33% of its $455B portfolio in Q1 2023.
  • Ken Griffin opened 1,466 new positions and closed 1,652 in Q1 2023.
  • Ken Griffin's portfolio value rose 6.2% quarter-over-quarter to $455B.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.